Transcenta Holding LimitedHKG 6628 Stock Report

Transcenta Holding Ltd. is a clinical stage global biopharmaceutical company that integrates the capacities of discovery, research, development, manufacturing and business development. The company is headquartered in Suzhou, Anhui and currently employs 321 full-time employees. The company went IPO on 2021-09-29. The firm's products include MSB2311, TST001, TST005, TST002, TST004, TST003, TST008, MSB0254 and TST006. The firm's all products are in the research and development (R&D) stage and have not been commercialized. The firm also provides contract developmentand manufacturing organization (CDMO) services, mainly including process development services, GMP / cGMP production services, cell line development services, sample testing services, formula optimization services and drug formation research.